McKesson Corporation (NYSE:MCK) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.73 by 13 Brokerage Firm. 7 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 4 Brokerage Firms have advised hold.
Several brokerage firms have commented on the stock rating. In the latest statement by the brokerage house, Cowen & Company downgrades its outlook on McKesson Corporation (NYSE:MCK). The current rating of the shares is Market Perform, according to the research report released by the firm. Previously, the company had a rating of Outperform. The brokerage firm lowers the price target from $208 per share to $173 per share. The rating by the firm was issued on March 15, 2016.
McKesson Corporation (NYSE:MCK): The mean short term price target for McKesson Corporation (NYSE:MCK) has been established at $197.8 per share. The higher price target estimate is at $237 and the lower price target estimate is expected at $164 according to 10 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $20.26
McKesson Corporation (NYSE:MCK) witnessed a decline in the market cap on Tuesday as its shares dropped 2.22% or 3.52 points. After the session commenced at $156.37, the stock reached the higher end at $157.56 while it hit a low of $154.33. With the volume soaring to 1,176,336 shares, the last trade was called at $154.69. The company has a 52-week high of $243.61. The company has a market cap of $35,360 million and there are 228,586,970 shares in outstanding. The 52-week low of the share price is $148.29.
McKesson Corporation has lost 2.63% in the last five trading days and dropped 4.96% in the last 4 weeks. McKesson Corporation has dropped 20.39% during the last 3-month period . Year-to-Date the stock performance stands at -21.43%.
McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two business segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services, including remote hosting and managed services, to healthcare organizations.